Results 261 to 270 of about 859,972 (336)

From Mechanisms to Management: Tackling In-Stent Restenosis in the Drug-Eluting Stent Era. [PDF]

Curr Cardiol Rep
Spadafora L, Quarta R, Martino G, Romano L, Greco F, Curcio A, Gori T, Spaccarotella C, Indolfi C, Polimeni A.   +9 more
europepmc   +1 more source

Catlet scoring system as a new predictor for in-stent restenosis in patients with chronic coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent. [PDF]

J Cardiothorac Surg
Wang J, Zhang M, Gan W, Xu M, Zhou J, Yang L, Ke Y.   +6 more
europepmc   +1 more source

Plasma Monocyte Chemoattractant Protein-1 Antigen Levels and the Risk of Restenosis After Coronary Stent Implantation

, 2001
Shuichi Oshima, Hisao Ogawa, Seiji Hokimoto, Shinichi Nakamura, Katsuo Noda, Taro Saito, Hirofumi Soejima, Keiji Takazoe, Fumiyuki Ishibashi, Hirofumi Yasue   +9 more
openalex   +2 more sources

Comparative Vascular Effects of Sirolimus and Everolimus on Isolated Human Saphenous Veins. [PDF]

Life (Basel)
Kaleli Durman D, Civelek E, Alp Yildirim Fİ, Teskin Ö, Uydeş Doğan BS.   +4 more
europepmc   +1 more source

Associations between endothelial progenitor cells, clinical characteristics and coronary restenosis in patients undergoing percutaneous coronary artery intervention. [PDF]

BMC Res Notes, 2018
Montenegro FS, Correia M, Muccillo F, Souza E Silva CG, De Lorenzo A.   +4 more
europepmc   +1 more source

Influence of boundary conditions and blood rheology on indices of wall shear stress from IVUS-based patient-specific stented coronary artery simulations. [PDF]

Sci Rep
McCarthy RP, Mason PJ, Marks DS, LaDisa JF.   +3 more
europepmc   +1 more source

Intravascular Lithotripsy for the Management of In-Stent Restenosis Due to Underexpanded Stents or Calcific Neo-Atherosclerosis: Outcomes From a Single-Center Study. [PDF]

Cureus
Kurpad KP, Kanakadandi U, Adoni N, Kumar S, Moussa ID, Mehta S.   +5 more
europepmc   +1 more source

Safety and Efficacy of a Paclitaxel-Coated Balloon for the Treatment of Symptomatic Patients with Long Superficial Femoral Artery Disease. [PDF]

Vasc Health Risk Manag
Sbarzaglia P, Galli M, Tenti E, Sangiorgi D, Lunetto ML, Russo P, Liso A, Pernice V, Micari A, Castriota F.   +9 more
europepmc   +1 more source

The Design and Feasibility of Optimal Treatment for Coronary Drug-Eluting Stent In-Stent Restenosis (OPEN-ISR)-A Prospective, Randomised, Multicentre Clinical Trial. [PDF]

J Pers Med
Kulyassa PM, Németh BT, Hizoh I, Jankó LK, Ruzsa Z, Jambrik Z, Balázs BB, Becker D, Merkely B, Édes IF.   +9 more
europepmc   +1 more source

Histopathologic Evaluation of Coronary Artery Thrombi Obtained by Directional Coronary Atherectomy in Patients With Restenosis-Induced Unstable Angina Pectoris

, 2001
Masayuki Terazawa, Shin-ichiro Morimoto, Haruo Hirayama, Shinya Hiramitsu, Hitoshi Hishida, Makoto Hirai, Hidehiko Saito   +6 more
openalex   +2 more sources